Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novavax Inc (NQ: NVAX ) 13.18 +0.22 (+1.70%) Streaming Delayed Price Updated: 9:49 AM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Novavax Inc < Previous 1 2 3 4 5 6 7 8 9 ... 54 55 Next > It’s Time! 3 Failing Biotech Stocks to Sell Right Now March 05, 2024 The biotech industry offers investors unique investment opportunities but these three are biotechs to sell. Via InvestorPlace Exit Alert: 3 Overhyped Stocks With Weak Fundamentals March 05, 2024 These are overhyped stocks to sell as they represent companies with weak fundamentals and prospects of cash burn. Via InvestorPlace Is Novavax a Buy Now? March 04, 2024 The stock has dropped 98% over the past three years. Via The Motley Fool 1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock? March 01, 2024 Can the stock's recent rally continue? Via The Motley Fool 10 Health Care Stocks Whale Activity In Today's Session February 29, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 28, 2024 Via Benzinga Novavax's Earnings Outlook February 27, 2024 Via Benzinga Has Novavax Just Solved Its Biggest Problem? February 27, 2024 The biotech company recently settled a dispute with a major customer. Via The Motley Fool Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 28, 2024 Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. Via Benzinga Why Is Advance Auto Parts (AAP) Stock Trending Today? February 28, 2024 Advance Auto Parts stock is up on Wednesday even after posting EPS and revenue misses in its earnings report for the fourth quarter of 2023. Via InvestorPlace Better Bull Market Buy: Novavax vs. Pfizer February 22, 2024 Bull markets usually favor stocks with promising growth prospects. Via The Motley Fool Where Will Novavax Be in 10 Years? February 15, 2024 Without any windfalls on the horizon, times are dire for this biotech. Via The Motley Fool Better Recovery Story Buy: Novavax vs. Teladoc February 03, 2024 Both stocks have fallen more than 90% from their peak. Via The Motley Fool Why Is COVID-19 Vaccine Maker Novavax Stock Plunging On Wednesday? February 28, 2024 Novavax reports Q4 2023 revenue of $291 million, missing consensus. Restructuring brings 30% workforce reduction. Anticipates COVID-19-Influenza combo vaccine Phase 3 in H2 2024. FY 2024 revenue... Via Benzinga Exposures COVID-19 NVAX Stock Alert: 9 Reasons Why Novavax Investors Are So Disappointed Today February 28, 2024 Novavax stock is falling hard on Wednesday as NVAX investors react to it missing estimates for Q4 and posting weak guidance for 2024! Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 28, 2024 Via Benzinga Beyond Meat, Viking Therapeutics, Novavax, Baidu, Tesla: Why These 5 Stocks Are On Investors' Radars Today February 27, 2024 The U.S. indices were mixed with the S&P 500 rising by nearly 0.2% to 5,078.18 and the Dow Jones Industrial Average falling by 0.25% to 38,972.41. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Thursday's Intraday Session February 22, 2024 Via Benzinga Could Novavax Stock Help You Become a Millionaire? February 01, 2024 Novavax aims to win with its coronavirus/flu vaccine candidate, now in clinical trials. Via The Motley Fool Earnings Scheduled For February 28, 2024 February 28, 2024 Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion. Via Benzinga Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 22, 2024 Shares of Etsy, Inc. Via Benzinga NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday February 22, 2024 U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday. Via Benzinga Topics Stocks Exposures US Equities Morgan Stanley Is Pounding the Table on DoorDash (DASH) Stock February 22, 2024 DoorDash stock is rising higher on Thursday after Morgan Stanley upgraded DASH shares and increased their price target for them. Via InvestorPlace Morgan Stanley Issues a Warning on Rivian (RIVN) Stock February 22, 2024 Rivian stock is falling hard on Friday as RIVN investors react to a warning from Morgan Stanley and a weak EV production guidance for 2024. Via InvestorPlace What's Going On With Novavax Stock Today? February 22, 2024 Novavax said it reached a settlement with Gavi related to the 2021 advance purchase agreement for Novavax's prototype COVID-19 vaccine. The agreement brings the pending arbitration related to the... Via Benzinga Exposures COVID-19 NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute February 22, 2024 Novavax stock is climbing higher on Thursday as investors in NVAX shares react to it reaching a $475 million settlement with Gavi. Via InvestorPlace Exposures COVID-19 Get Rich Quick With These 3 Stocks to Buy Now February 15, 2024 Although these market ideas are extremely speculative, their upcoming catalysts could make them stocks to buy now. Via InvestorPlace 3 Doomed Biotech Stocks to Dump Before They Dive: February 2024 February 11, 2024 Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly. Via InvestorPlace 3 Beaten-Down Growth Stocks that Could Take off in the New Bull Market February 05, 2024 Bull markets favor growth stocks so now could be the time for these players to shine. Via The Motley Fool Novavax's Malaria Vaccine Gets WHO Prequalification, Has Potential Of Being An Affordable Option February 02, 2024 Novavax's R21/Matrix-M malaria vaccine, with 75% efficacy in seasonal areas. Affordable at $3 per dose, it outshines GSK's vaccine. Global rollout expected mid-2024. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 54 55 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.